Ropivacaine Plus Magnesium Sulphate Infiltration

NCT05294393 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Diseases
Parathyroid Diseases
Postoperative Pain
Anesthesia, Local

Interventions

DRUG: Placebo Comparator: N/S 0.9%
DRUG: Ropivacaine 10%
DRUG: Ropivacaine 10% plus magnesium sulphate 10mg/kg

Sponsor

Aristotle University Of Thessaloniki